{"entity":{"type":"insider","cik":"0001785406","url":"/insider/0001785406","json_url":"/insider/0001785406.json","name":"FORD KATHLEEN","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":13,"first":"2020-09-15","last":"2026-05-20","span_basis":"filed_date"},"name_variants":[{"name":"FORD KATHLEEN","source":"filing","n_filings":13,"first_seen":"2020-09-15","last_seen":"2026-05-20"}],"transactions":[{"id":6017600,"accession":"0001193125-26-232548","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-232548","line_url":"/filing/0001193125-26-232548#line-1","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001785406","owner_name":"FORD KATHLEEN","owner_display_name":"FORD KATHLEEN","owner_url":"/insider/0001785406","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2257.0,"shares_display":"2,257","price_per_share":9.0752,"price_display":"9.08","price_state":"stated","total_value":20482.7264,"total_display":"20,482.73","total_whole":"20,483","shares_owned_after":153560.0,"shares_owned_after_display":"153,560","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-19","filed_date":"2026-05-20","scope":"insider"},{"id":6194403,"accession":"0001193125-26-025304","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-025304","line_url":"/filing/0001193125-26-025304#line-1","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001785406","owner_name":"FORD KATHLEEN","owner_display_name":"FORD KATHLEEN","owner_url":"/insider/0001785406","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1813.0,"shares_display":"1,813","price_per_share":8.4607,"price_display":"8.46","price_state":"stated","total_value":15339.2491,"total_display":"15,339.25","total_whole":"15,339","shares_owned_after":153560.0,"shares_owned_after_display":"153,560","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-27","filed_date":"2026-01-27","scope":"insider"},{"id":4343920,"accession":"0001193125-25-283560","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-283560","line_url":"/filing/0001193125-25-283560#line-2","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001785406","owner_name":"FORD KATHLEEN","owner_display_name":"FORD KATHLEEN","owner_url":"/insider/0001785406","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6902.0,"shares_display":"6,902","price_per_share":11.1769,"price_display":"11.18","price_state":"stated","total_value":77142.9638,"total_display":"77,142.96","total_whole":"77,143","shares_owned_after":105373.0,"shares_owned_after_display":"105,373","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-14","filed_date":"2025-11-14","scope":"insider"},{"id":4754708,"accession":"0001193125-25-223665","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-223665","line_url":"/filing/0001193125-25-223665#line-2","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001785406","owner_name":"FORD KATHLEEN","owner_display_name":"FORD KATHLEEN","owner_url":"/insider/0001785406","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6892.0,"shares_display":"6,892","price_per_share":8.9422,"price_display":"8.94","price_state":"stated","total_value":61629.6424,"total_display":"61,629.64","total_whole":"61,630","shares_owned_after":63375.0,"shares_owned_after_display":"63,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-29","filed_date":"2025-09-29","scope":"insider"},{"id":4946426,"accession":"0000950170-25-074659","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-074659","line_url":"/filing/0000950170-25-074659#line-1","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001785406","owner_name":"FORD KATHLEEN","owner_display_name":"FORD KATHLEEN","owner_url":"/insider/0001785406","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1558.0,"shares_display":"1,558","price_per_share":6.2756,"price_display":"6.28","price_state":"stated","total_value":9777.3848,"total_display":"9,777.38","total_whole":"9,777","shares_owned_after":21367.0,"shares_owned_after_display":"21,367","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-19","filed_date":"2025-05-19","scope":"insider"},{"id":4098923,"accession":"0000950170-25-010118","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-010118","line_url":"/filing/0000950170-25-010118#line-1","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001785406","owner_name":"FORD KATHLEEN","owner_display_name":"FORD KATHLEEN","owner_url":"/insider/0001785406","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1817.0,"shares_display":"1,817","price_per_share":7.8719,"price_display":"7.87","price_state":"stated","total_value":14303.2423,"total_display":"14,303.24","total_whole":"14,303","shares_owned_after":21367.0,"shares_owned_after_display":"21,367","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-28","filed_date":"2025-01-28","scope":"insider"},{"id":2311154,"accession":"0000950170-24-128558","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-128558","line_url":"/filing/0000950170-24-128558#line-1","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001785406","owner_name":"FORD KATHLEEN","owner_display_name":"FORD KATHLEEN","owner_url":"/insider/0001785406","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":526.0,"shares_display":"526","price_per_share":16.0337,"price_display":"16.03","price_state":"stated","total_value":8433.7262,"total_display":"8,433.73","total_whole":"8,434","shares_owned_after":23184.0,"shares_owned_after_display":"23,184","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-18","filed_date":"2024-11-19","scope":"insider"},{"id":2274105,"accession":"0000950170-24-009494","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-009494","line_url":"/filing/0000950170-24-009494#line-1","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001785406","owner_name":"FORD KATHLEEN","owner_display_name":"FORD KATHLEEN","owner_url":"/insider/0001785406","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1496.0,"shares_display":"1,496","price_per_share":17.8005,"price_display":"17.80","price_state":"stated","total_value":26629.548,"total_display":"26,629.55","total_whole":"26,630","shares_owned_after":21602.0,"shares_owned_after_display":"21,602","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-29","filed_date":"2024-01-31","scope":"insider"},{"id":8287571,"accession":"0001209191-23-005753","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-005753","line_url":"/filing/0001209191-23-005753#line-1","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001785406","owner_name":"FORD KATHLEEN","owner_display_name":"FORD KATHLEEN","owner_url":"/insider/0001785406","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1821.0,"shares_display":"1,821","price_per_share":13.8901,"price_display":"13.89","price_state":"stated","total_value":25293.8721,"total_display":"25,293.87","total_whole":"25,294","shares_owned_after":21214.0,"shares_owned_after_display":"21,214","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-27","filed_date":"2023-01-31","scope":"insider"},{"id":4661298,"accession":"0001209191-21-021320","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-021320","line_url":"/filing/0001209191-21-021320#line-2","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001785406","owner_name":"FORD KATHLEEN","owner_display_name":"FORD KATHLEEN","owner_url":"/insider/0001785406","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6250.0,"shares_display":"6,250","price_per_share":29.4321,"price_display":"29.43","price_state":"stated","total_value":183950.625,"total_display":"183,950.62","total_whole":"183,951","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-17","scope":"insider"},{"id":2660107,"accession":"0001209191-20-063764","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-063764","line_url":"/filing/0001209191-20-063764","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001785406","owner_name":"FORD KATHLEEN","owner_display_name":"FORD KATHLEEN","owner_url":"/insider/0001785406","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9375.0,"shares_display":"9,375","price_per_share":40.60443333333333,"price_display":"40.60","price_state":"stated","total_value":380666.5625,"total_display":"380,666.56","total_whole":"380,667","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-15","filed_date":"2020-12-16","scope":"insider","n_lines":2},{"id":3019083,"accession":"0001209191-20-058020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-058020","line_url":"/filing/0001209191-20-058020#line-2","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001785406","owner_name":"FORD KATHLEEN","owner_display_name":"FORD KATHLEEN","owner_url":"/insider/0001785406","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6250.0,"shares_display":"6,250","price_per_share":39.43,"price_display":"39.43","price_state":"stated","total_value":246437.5,"total_display":"246,437.50","total_whole":"246,438","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-10","filed_date":"2020-11-12","scope":"insider"},{"id":2443999,"accession":"0001209191-20-050596","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-050596","line_url":"/filing/0001209191-20-050596#line-4","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001785406","owner_name":"FORD KATHLEEN","owner_display_name":"FORD KATHLEEN","owner_url":"/insider/0001785406","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6250.0,"shares_display":"6,250","price_per_share":29.43,"price_display":"29.43","price_state":"stated","total_value":183937.5,"total_display":"183,937.50","total_whole":"183,938","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-15","filed_date":"2020-09-15","scope":"insider"},{"id":2443992,"accession":"0001209191-20-050596","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-050596","line_url":"/filing/0001209191-20-050596#line-2","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001785406","owner_name":"FORD KATHLEEN","owner_display_name":"FORD KATHLEEN","owner_url":"/insider/0001785406","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6250.0,"shares_display":"6,250","price_per_share":29.43,"price_display":"29.43","price_state":"stated","total_value":183937.5,"total_display":"183,937.50","total_whole":"183,938","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-14","filed_date":"2020-09-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001422143","name":"Kura Oncology, Inc.","url":"/issuer/0001422143","role":"Officer (Chief Operating Officer)","n_filings":13,"first_seen":"2020-09-15","last_seen":"2026-05-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001785406","retrieved_at":"2026-08-26T19:03:57+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}